NCT06088147Status unknown
Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata
Methotrexate With Microneedling Versus Triamcinilone Acetonide With Microneedling in Treatment of Recalcitrant Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Al-Azhar University
- Participants (registry)
- 34
- Start
- December 2023
- Primary completion
- March 2024
- Study completion
- June 2024
- Last registry update
- November 2023
- Countries
- Egypt
Conditions studied: Alopecia Areata
Interventions: Methotrexate, Triamcinolone Acetonide
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.